Physician

Adeel Shahid Khan, MD

According to 2025 Medicare claims, Adeel Khan, MD (NPI: 1982822763) practices general surgery in the St. Louis, MO-IL market, with the plurality of this provider's patient population coming from Madison, IL. This provider's primary affiliated billing organization is WASHINGTON UNIVERSITY (NPI: 1134169568; TIN: 430653611) and primary practice location at 63110-1003. Khan is affiliated with the BJC HealthCare ACO, LLC (ACO ID: A1204) and IRCCO (ACO ID: A2619), participating under the MSSP model.

Khan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 70 traditional Medicare patients, billed 163 HCPCS/CPT codes, and received $96,789 in Medicare payments. The top billing code was 99232 (Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes). Part D data shows 308 prescription claims across 22 beneficiaries totaling $31,414 in drug costs, led by Atovaquone (Atovaquone). DME data shows 231 claims. Open Payments data shows 90 records totaling $64,476. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $2,906 and ending at $31,414. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $4,358 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	270	811	$101,086
2016	26	32	$14,221
2017	65	130	$68,567
2018	133	320	$150,833
2019	171	434	$180,061
2020	154	439	$184,121
2021	144	407	$166,162
2022	92	215	$147,286
2023	69	173	$121,432
2024	70	163	$96,789

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	75	134	$2,906
2016	N/R	N/R	N/R
2017	N/R	23	$4,744
2018	26	200	$41,508
2019	29	213	$20,327
2020	17	47	$6,071
2021	N/R	23	$2,335
2022	N/R	21	$2,340
2023	N/R	50	$9,171
2024	22	308	$31,414

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	45	302	$59,633
2019	30	188	$48,524
2020	N/R	51	$2,761
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	231	$38,265

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	25	42	$59

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Atovaquone	Atovaquone	13	380	$5,577
Valganciclovir Hcl	Valganciclovir Hcl	37	1,219	$4,595
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	68	2,193	$389
Pantoprazole Sodium	Pantoprazole Sodium	65	2,160	$227
Prednisone	Prednisone	14	420	$71

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7503	Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg	N	N/R	47	$34,269
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	30	$1,466
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	83	$1,041
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	19	$824
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	34	$640

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	90	$64,476	INTUITIVE SURGICAL, INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adeel Shahid Khan, MD?

Tedicare shows public-source Medicare data for Adeel Shahid Khan, MD (NPI 1982822763), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adeel Shahid Khan, MD have ACO affiliation data?

Adeel Shahid Khan, MD is shown with ACO affiliation data for BJC HealthCare ACO, LLC (MSSP, ACO ID A1204) and IRCCO (MSSP, ACO ID A2619).

What billing organization is linked to Adeel Shahid Khan, MD?

Adeel Shahid Khan, MD is linked to WASHINGTON UNIVERSITY (billing NPI 1134169568) in the available physician profile data.

Does Adeel Shahid Khan, MD have Open Payments data?

Adeel Shahid Khan, MD has 90 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.